FDA report a disservice to fibroids patientsThe U.S. Food and Drug Administration (FDA) has done women a disservice by incompletely examining the evidence for risk and benefits associated with morcellation for women undergoing surgery for suspected fibroids. Of note, within days of the FDA report, the Agency for Healthcare Quality and Research (AHRQ) of the US Department of Health and Human Services published a more rigorous and complete analysis of available data with entirely different results and conclusions. Thirty-six signees recommend that Contemporary OB/GYN’s readers review the AHRQ findings and decide which report serves women best.
Optimal approaches to fibroid managementFibroids are extremely common in women of reproductive age. One large study reported that 70% of Caucasian and 80% of African-American women had at least one ultrasound- or pathology-confirmed fibroid by the end of their reproductive years. While many of these women experience no negative effects of fibroids on their reproductive function, a significant number are at increased risk of infertility, miscarriage, or poor obstetric outcomes.
Morcellator manufacturer investigated by FBIThe FBI is investigating how much the manufacturer knew about the safety of the design. Plus, how does the clotting profile of new oral contraceptives compare to earlier formulations and a look at the impact of the PALB2 mutation on breast cancer prognosis.
Morcellation risk outweighed by risks of laparotomyMore information on the risks of morcellation when treating fibroids; a look at the price tag associated with post-fracture use of bisphosphonates; and research on the developmental impact of a variety of air pollution.
Heavy or prolonged bleeding in menopause is not uncommon
Heavy or prolonged bleeding in menopause is not uncommonWomen undergoing the menopausal transition may be prone to prolonged bleeding with periods of heaviness, according to a new study in BJOG.
Fibroids affect more than health in African Americans
Fibroids affect more than health in African AmericansUterine fibroids can have a significant impact on the health, workplace performance and quality of life of women—particularly African-American women—according to a new study published in the American Journal of Obstetrics and Gynecology.